Detoxification Pathways Practice Questions

Q: One of the obvious consequences of alcohol (ethanol) ingestion in many individuals is facial flushing and increased heart rate, triggered off by alcohol getting metabolized to what compound?

Acetaldehyde. ### Explanation **Correct Answer: B. Acetaldehyde** **Mechanism:** Ethanol is primarily metabolized in the liver by the enzyme **Alcohol Dehydrogenase (ADH)** into **Acetaldehyde**. Acetaldehyde is a highly reactive and toxic intermediate. In many individuals, particularly those with a genetic deficiency or reduced activity of **Aldehyde Dehydrogenase (ALDH2)**, acetaldehyde accumulates in the blood. This accumulation triggers the release of histamine and catecholamines, leading to peripheral vasodilation (facial flushing), tachycardia (increased heart rate), nausea, and palpitations. This physiological reaction is commonly known as the "Alcohol Flush Reaction." **Analysis of Incorrect Options:** * **A. Formaldehyde:** This is the toxic metabolite of **Methanol**. Formaldehyde is further oxidized to formic acid, which causes optic nerve damage and metabolic acidosis. * **C & D. Propanaldehyde and Butanaldehyde:** These are aldehydes derived from propanol and butanol, respectively. They are not produced during the normal metabolic pathway of ethanol ingestion. **High-Yield Clinical Pearls for NEET-PG:** * **Disulfiram (Antabuse):** This drug inhibits the enzyme **ALDH**, causing an intentional accumulation of acetaldehyde if alcohol is consumed. This produces an unpleasant "Disulfiram-like reaction," used as aversion therapy in chronic alcoholism. * **Drugs causing Disulfiram-like reactions:** Metronidazole (most common), Cefotetan, Griseofulvin, and Sulfonylureas (Tolbutamide). * **Rate-limiting step:** The conversion of ethanol to acetaldehyde by ADH is a **zero-order kinetics** process (constant amount of drug eliminated per unit time). * **Co-enzyme:** Both ADH and ALDH require **NAD+** as a co-enzyme, leading to an increased NADH/NAD+ ratio in alcoholics, which contributes to lactic acidosis and fatty liver.

Q: All of the following help in the detoxification of drugs except?

Cytochrome oxidase. **Explanation:** The detoxification of drugs and xenobiotics primarily occurs in the liver through the **Microsomal Mixed-Function Oxidase System** (located in the smooth endoplasmic reticulum). **Why Cytochrome Oxidase is the correct answer:** Cytochrome oxidase (also known as **Cytochrome c oxidase** or Complex IV) is a key enzyme in the **Electron Transport Chain (ETC)** located in the inner mitochondrial membrane. Its primary role is cellular respiration—transferring electrons to oxygen to form water and generate ATP. It is **not** involved in the metabolic degradation or detoxification of drugs. **Analysis of Incorrect Options (Involved in Detoxification):** * **Cytochrome P450 (B) & NADPH cytochrome P450 reductase (A):** These are the core components of the Phase I detoxification system. The reductase transfers electrons from NADPH to Cytochrome P450, which then binds to the drug and oxygen to perform oxidative reactions [1]. * **Monooxygenase (D):** This is a functional name for the Cytochrome P450 system. These enzymes incorporate one atom of molecular oxygen into the substrate (the drug) and reduce the other atom to water, making the drug more polar and easier to excrete. **High-Yield Clinical Pearls for NEET-PG:** * **Phase I Reactions:** Include Oxidation (most common), Reduction, and Hydrolysis. These reactions usually make a drug more hydrophilic but can sometimes produce toxic intermediates (e.g., NAPQI from Paracetamol). * **Phase II Reactions:** Involve Conjugation (e.g., Glucuronidation, Sulfation). **Glucuronidation** is the most common Phase II reaction. * **Inducers vs. Inhibitors:** Phenytoin and Rifampicin are potent CYP450 **inducers**, while Ketoconazole and Cimetidine are potent **inhibitors**. * **Inhibition of Cytochrome Oxidase:** Cyanide and Carbon Monoxide (CO) toxicity occurs by binding to and inhibiting Cytochrome oxidase (Complex IV), halting ATP production.

Q: A 45-year-old woman has been admitted to a substance abuse center for her alcoholism. As a first attempt to curb the patient's drinking, she is given a drug that will lead to an elevation of which one of the following metabolites if she drinks alcohol?

Acetaldehyde. ### Explanation The correct answer is **Acetaldehyde**. **Mechanism of Action:** The drug described is **Disulfiram**, which is used as an aversion therapy for chronic alcoholism. Alcohol metabolism follows a two-step oxidative pathway: 1. **Ethanol** is converted to **Acetaldehyde** by the enzyme *Alcohol Dehydrogenase (ADH)*. 2. **Acetaldehyde** is then converted to **Acetic acid** (Acetate) by the enzyme *Aldehyde Dehydrogenase (ALDH)*. Disulfiram acts by irreversibly inhibiting **Aldehyde Dehydrogenase**. If the patient consumes alcohol while on this medication, acetaldehyde cannot be converted to acetic acid, leading to its rapid accumulation in the blood. This results in the **Disulfiram-like reaction**, characterized by flushing, tachycardia, nausea, vomiting, and hypotension, which serves as a deterrent to drinking. **Analysis of Incorrect Options:** * **A. Acetic acid:** This is the product of acetaldehyde metabolism. Since ALDH is inhibited, the levels of acetic acid will decrease, not increase. * **C. Ethanol:** While ethanol levels remain high if not metabolized, the specific "toxic" metabolite responsible for the clinical symptoms of the drug-alcohol interaction is acetaldehyde. * **D. Carbon dioxide:** This is the end product of the complete oxidation of acetate in the TCA cycle. Its levels are not acutely elevated by Disulfiram. **High-Yield Clinical Pearls for NEET-PG:** * **Disulfiram-like reaction** can also be caused by other drugs: **Metronidazole** (most common), **Sulfonylureas** (1st gen like Chlorpropamide), **Griseofulvin**, and certain **Cephalosporins** (Cefoperazone, Cefotetan). * **Fomepizole** (inhibits Alcohol Dehydrogenase) is the antidote for Methanol and Ethylene glycol poisoning. * Alcohol metabolism follows **Zero-order kinetics** (a constant amount of drug is eliminated per unit time).

Q: Where is Cytochrome 450 primarily located?

Endoplasmic reticulum. **Explanation:** Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing proteins primarily involved in the oxidative metabolism of drugs, toxins, and endogenous compounds like steroids. **Why Endoplasmic Reticulum (ER) is correct:** The vast majority of CYP450 enzymes are integral membrane proteins located in the **Smooth Endoplasmic Reticulum (SER)**, particularly in hepatocytes. These are often referred to as "microsomal" enzymes because, during cell fractionation, the ER fragments into vesicles called microsomes. They play a critical role in Phase I metabolism (hydroxylation, oxidation) to make lipophilic compounds more water-soluble for excretion. **Why other options are incorrect:** * **Mitochondria:** While a specific subset of CYP450 enzymes exists in the inner mitochondrial membrane (involved in steroidogenesis and Vitamin D activation), the **primary** and most abundant location discussed in general pharmacology and biochemistry is the ER. * **Cytoplasm:** CYP450 enzymes are membrane-bound to facilitate the electron transport chain required for their catalytic cycle; they do not function as soluble proteins in the cytosol. * **Golgi apparatus:** This organelle is involved in protein modification and trafficking, not the oxidative metabolism characteristic of the CYP450 system. **High-Yield NEET-PG Pearls:** * **Inducers vs. Inhibitors:** Knowledge of CYP450 inducers (e.g., Rifampicin, Phenytoin, Carbamazepine) and inhibitors (e.g., Ketoconazole, Erythromycin, Cimetidine) is high-yield for both Biochemistry and Pharmacology. * **CYP3A4:** This is the most abundant isoform in the liver and is responsible for metabolizing nearly 50% of all clinical drugs. * **Requirement:** The CYP450 system requires **NADPH** and **Molecular Oxygen (O₂)** to function.

Q: Which of the following is metabolized like xenobiotics?

Bilirubin. **Explanation:** The metabolism of **Bilirubin** is the classic physiological example of how the body handles an endogenous waste product using the same machinery designed for **xenobiotic detoxification** (biotransformation). **Why Bilirubin is the Correct Answer:** Xenobiotic metabolism typically involves two phases: **Phase I** (Functionalization, e.g., hydroxylation) and **Phase II** (Conjugation). Bilirubin, produced from heme degradation, is highly lipophilic and toxic. To be excreted, it must be made water-soluble. It undergoes **Phase II conjugation** in the liver, where the enzyme **UDP-glucuronosyltransferase (UGT1A1)** attaches glucuronic acid molecules to it, forming Bilirubin Diglucuronide. This process is identical to how many drugs and toxins are processed for biliary or renal excretion. **Analysis of Incorrect Options:** * **Myoglobin & Haemoglobin (A & D):** These are complex functional metalloproteins. They are not "metabolized" like small-molecule xenobiotics; rather, they are degraded into their constituent amino acids (recycled) and heme groups. * **Biliverdin (C):** This is an intermediate in heme catabolism. While it is a precursor to bilirubin, it is green, water-soluble, and does not require the complex conjugation machinery (Phase II) that characterizes xenobiotic-like detoxification. **High-Yield Clinical Pearls for NEET-PG:** * **Phase II Enzyme:** UDP-glucuronosyltransferase is the key enzyme. A deficiency leads to **Crigler-Najjar** or **Gilbert Syndrome**. * **Induction:** Phenobarbital can induce the UGT enzyme, which is why it is sometimes used to treat certain types of hyperbilirubinemia. * **Excretion:** Conjugated bilirubin is water-soluble and excreted in bile via the **MRP2 transporter** (defective in Dubin-Johnson Syndrome).

Q: Which of the following is a product formed from alcohol but not an intermediate of the TCA cycle or glycolysis?

Acetaldehyde. **Explanation:** The metabolism of ethanol primarily occurs in the liver via a two-step oxidative process. Ethanol is first converted into **Acetaldehyde** by the enzyme *Alcohol Dehydrogenase (ADH)* in the cytosol. Acetaldehyde is then further oxidized to Acetate by *Aldehyde Dehydrogenase (ALDH)* in the mitochondria. While Acetate eventually enters the TCA cycle as Acetyl-CoA, **Acetaldehyde** itself is a specific metabolic byproduct of alcohol that does not exist as an intermediate in either Glycolysis or the TCA cycle. **Analysis of Options:** * **Pyruvate (Option B):** This is the end-product of aerobic glycolysis and a key substrate for the TCA cycle (via conversion to Acetyl-CoA). * **Lactate (Option C):** This is the end-product of anaerobic glycolysis. While alcohol metabolism increases the NADH/NAD+ ratio, shifting pyruvate toward lactate, lactate is a standard glycolytic metabolite. * **Oxalate (Option D):** This is a metabolic byproduct of ethylene glycol (toxic alcohol) or glycine metabolism, but it is not a normal intermediate of the TCA cycle or the primary ethanol pathway. **Clinical Pearls for NEET-PG:** 1. **NADH/NAD+ Ratio:** Alcohol metabolism significantly increases the NADH/NAD+ ratio, which inhibits gluconeogenesis (leading to fasting hypoglycemia) and shifts the balance from pyruvate to lactate (leading to lactic acidosis). 2. **Disulfiram (Antabuse):** This drug inhibits *Aldehyde Dehydrogenase*, causing an accumulation of Acetaldehyde. This results in the "Disulfiram-like reaction" (flushing, tachycardia, nausea). 3. **Microsomal Ethanol Oxidizing System (MEOS):** In chronic alcoholics, the CYP2E1 pathway is induced to handle high ethanol loads.

Q: What is the primary rationale behind xenobiotic metabolism by CYP enzymes?

Increases water solubility. **Explanation:** The primary goal of xenobiotic metabolism (biotransformation) is to facilitate the excretion of foreign substances from the body. Most xenobiotics are lipophilic, allowing them to cross cell membranes easily; however, this property also causes them to be reabsorbed in the renal tubules rather than excreted in urine. **Why Option A is correct:** CYP enzymes (Cytochrome P450), primarily involved in **Phase I reactions** (oxidation, reduction, hydrolysis), introduce or expose polar functional groups (like -OH, -NH2, or -SH). This increases the **water solubility (hydrophilicity)** of the compound. Increased water solubility ensures that the metabolite remains in the aqueous environment of the renal tubule or bile, preventing reabsorption and promoting excretion. **Why other options are incorrect:** * **Option B:** Increasing lipid solubility would lead to the accumulation of toxins in adipose tissue and constant reabsorption in the kidneys, preventing elimination. * **Option C:** While some drugs are administered as "prodrugs" and require CYP enzymes for activation (e.g., Clopidogrel), this is a pharmacological strategy rather than the *primary biological rationale* of the system, which is detoxification. * **Option D:** Evaporation through the skin is a negligible route for xenobiotic elimination; the renal and biliary routes are the primary pathways. **High-Yield Clinical Pearls for NEET-PG:** * **Phase I vs. Phase II:** Phase I (CYP-mediated) increases polarity. Phase II (Conjugation, e.g., Glucuronidation) significantly increases water solubility for excretion. * **CYP3A4:** The most abundant CYP enzyme in the liver, responsible for metabolizing ~50% of clinical drugs. * **Inducers vs. Inhibitors:** Rifampicin and Phenytoin are classic **inducers** (decrease drug levels), while Ketoconazole and Grapefruit juice are **inhibitors** (increase drug toxicity).

Q: In chronic alcoholism, which component, excluding enzymes, is rate-limiting for alcohol metabolism?

NAD+. **Explanation:** The metabolism of ethanol primarily occurs in the liver via two major oxidative steps. First, **Alcohol Dehydrogenase (ADH)** converts ethanol to acetaldehyde. Second, **Acetaldehyde Dehydrogenase (ALDH)** converts acetaldehyde to acetate. Both of these reactions require **NAD+** as a necessary co-factor, reducing it to **NADH**. In chronic alcoholism, the high rate of ethanol oxidation leads to a massive consumption of the cellular NAD+ pool. Because the body cannot regenerate NAD+ from NADH fast enough to keep up with heavy intake, the **NAD+/NADH ratio falls significantly**. Consequently, the availability of **NAD+** becomes the **rate-limiting factor** for alcohol clearance, rather than the enzyme concentration itself. **Analysis of Incorrect Options:** * **NADP & NADPH (Options A & C):** These are primarily involved in reductive biosynthesis (e.g., fatty acid synthesis) and the microsomal ethanol oxidizing system (MEOS). While MEOS uses NADPH and is induced in chronic alcoholics, it is a secondary pathway and not the primary rate-limiting component for bulk alcohol metabolism. * **FADH (Option D):** FADH2 is involved in the electron transport chain and certain TCA cycle reactions (like succinate dehydrogenase) but is not a co-factor for the primary ADH or ALDH enzymes. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolic Consequences:** The high NADH:NAD+ ratio shifts the equilibrium of other reactions, leading to **lactic acidosis** (pyruvate → lactate), **fasting hypoglycemia** (inhibited gluconeogenesis), and **steatosis** (increased fatty acid synthesis). * **Zero-Order Kinetics:** Alcohol metabolism follows zero-order kinetics because the NAD+ co-factor is easily saturated. * **Disulfiram:** Inhibits ALDH, causing acetaldehyde accumulation, leading to the "hangover" symptoms used in aversion therapy.

Question 1

In the liver, which of the following is responsible for the metabolism of alcohol?

Accepted Answer

All of the above

Answer

Alcohol dehydrogenase (ADH)

Answer

Aldehyde dehydrogenase (ALDH)

Answer

Microsomal ethanol-oxidizing system (MEOS)

Question 2

One of the obvious consequences of alcohol (ethanol) ingestion in many individuals is facial flushing and increased heart rate, triggered off by alcohol getting metabolized to what compound?

Accepted Answer

Acetaldehyde

Answer

Formaldehyde

Answer

Propanaldehyde

Answer

Butanaldehyde

Question 3

All of the following help in the detoxification of drugs except?

Accepted Answer

Cytochrome oxidase

Answer

NADPH cytochrome P450 reductase

Answer

Cytochrome P450

Answer

Monooxygenase

Question 4

A 45-year-old woman has been admitted to a substance abuse center for her alcoholism. As a first attempt to curb the patient's drinking, she is given a drug that will lead to an elevation of which one of the following metabolites if she drinks alcohol?

Accepted Answer

Acetaldehyde

Answer

Acetic acid

Answer

Ethanol

Answer

Carbon dioxide

Question 5

Where is Cytochrome 450 primarily located?

Accepted Answer

Endoplasmic reticulum

Answer

Mitochondria

Answer

Cytoplasm

Answer

Golgi apparatus

Question 6

Which of the following is metabolized like xenobiotics?

Accepted Answer

Bilirubin

Answer

Myoglobin

Answer

Biliverdin

Answer

Haemoglobin

Question 7

Which of the following is a product formed from alcohol but not an intermediate of the TCA cycle or glycolysis?

Accepted Answer

Acetaldehyde

Answer

Pyruvate

Answer

Lactate

Answer

Oxalate

Question 8

What is the primary rationale behind xenobiotic metabolism by CYP enzymes?

Accepted Answer

Increases water solubility

Answer

Increases lipid solubility

Answer

Conversion to an active metabolite

Answer

Makes it suitable for evaporation through the skin surface

Question 9

In chronic alcoholism, which component, excluding enzymes, is rate-limiting for alcohol metabolism?

Accepted Answer

NAD+

Answer

NADP

Answer

NADPH

Answer

FADH

Question 10

Which of the following is the main enzyme responsible for the activation of xenobiotics?

Accepted Answer

Cytochrome P-450

Answer

Glucuronyl transferase

Answer

Glutathione S-transferase

Answer

NADPH cytochrome P-450-reductase

Detoxification Pathways — MCQs

Detoxification Pathways — MCQs

On this page

Practice by Chapter

Want unlimited practice?